Pharmaceuticals
Medication-Associated Xerostomia and Oral Symptom Burden in Midlife Women: A Drug Safety Perspective Across the Menopausal Transition
Door Angela Dragomir, Radu Dumitru Moleriu, Ruxandra-Cristina Marin en 7 anderen.
Inhoud in het Engels
Abstract
Background/Objectives: Medication-associated xerostomia is a clinically relevant adverse effect, but its contribution to oral symptom burden in midlife women remains insufficiently characterized. This study investigated the association between xerogenic medication exposure and xerostomia burden across the menopausal transition and whether this association extended to broader oral symptoms.